HNRNPK and nasopharyngeal carcinoma: In summary, our study revealed that seRNA LOC100506178 indirectly enhances MICAL2, Vimentin, and Snail expression, and decreasing E-cadherin expression by specifically upregulating hnRNPK, which promotes EMT and NPC malignancy (Fig. 8C).